Novocure Ltd.
(NASDAQ : NVCR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.39%82.340.6%$498.85m
TMOThermo Fisher Scientific Inc.
-0.11%192.721.0%$317.11m
ALGNAlign Technology, Inc.
-0.80%254.386.3%$298.99m
ABTAbbott Laboratories
-0.57%55.800.8%$291.46m
BDXBecton, Dickinson and Company
-1.16%224.201.3%$286.91m
ISRGIntuitive Surgical, Inc.
-0.48%396.592.5%$274.70m
EWEdwards Lifesciences Corporation
-0.65%108.811.2%$201.16m
BSXBoston Scientific Corporation
-1.15%28.471.1%$198.26m
SYKStryker Corporation
-0.62%154.771.3%$181.84m
ZBHZimmer Biomet Holdings, Inc.
-0.40%113.111.7%$167.58m
BAXBaxter International Inc.
-0.33%64.041.7%$163.81m
BCRC. R. Bard, Inc.
-0.48%335.031.6%$159.46m
XRAYDENTSPLY International Inc.
0.87%67.593.0%$135.94m
HOLXHologic, Inc.
0.69%40.881.7%$128.88m
IDXXIDEXX Laboratories, Inc.
-0.98%154.063.7%$93.80m

Company Profile

Novocure Ltd. operates as a commercial-stage oncology company, which offers devices for continuous home use by patients. It develops novottf-100A, a portable non-invasive investigational device for cancer treatment using tumor treating fields. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.